Headquartered in the Netherlands, Intervet[1], founded in 1969, has a global presence. It was the third-largest veterinary pharmaceutical company in the world. There are Intervet products to help almost every species--from birds to farm animals and horses. The company has been well-known for its work in veterinary vaccines and other platforms. It is best-known to us with diabetic pets as the producer of Caninsulin (known in some countries as Vetsulin), a U40 porcine Lente insulin.
Intervet was one of the three companies that made up Akzo-Nobel's pharmaceutical division. Completing the division are Organon, a human pharmaceutical company (its first product was insulin in 1923)[2] and Diosynth, which makes biotech and traditional pharmaceutical raw materials (among them, insulin extracted from animal pancreases since 1923)[3][4].
Intervet has now merged with Schering-Plough Animal Health; both companies are currently in the process of merging with Merck.
References[]
All items (0)